Raymond James Financial Services Advisors’s Axonics, Inc. Common Stock AXNX Stock Holding History

Raymond James Financial Services Advisors’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,113	Closed	-$290K	–	3422
2022 Q2	$290K	Sell	5,113 -94	-2%	-$5.15K	﹤0.01%	2618
2022 Q1	$326K	Buy	5,207 +326	+7%	+$17.6K	﹤0.01%	2660
2021 Q4	$273K	Sell	4,881 -973	-17%	-$59.5K	﹤0.01%	2783
2021 Q3	$381K	Sell	5,854 -263	-4%	-$17.9K	﹤0.01%	2538
2021 Q2	$388K	Buy	6,117 +108	+2%	+$6.38K	﹤0.01%	2542
2021 Q1	$360K	Buy	+6,009	New	+$327K	﹤0.01%	2509

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Raymond James Financial Services Advisors's AXNX Position: Q3 2022 in Review

Raymond James Financial Services Advisors sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2022, closing a stake of 5,113 shares — an estimated $290K sold.

Raymond James Financial Services Advisors first reported a position in AXNX in Q1 2021 and held it in 6 quarters. The position peaked at $388K in Q2 2021. 230 funds tracked by Wall St. Rank hold AXNX as of Q3 2022.

Raymond James Financial Services Advisors reported no remaining Axonics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Raymond James Financial Services Advisors sold 5,113 Axonics, Inc. Common Stock shares in Q3 2022, an estimated $290K.
Raymond James Financial Services Advisors first reported a position in Axonics, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
Raymond James Financial Services Advisors's Axonics, Inc. Common Stock position peaked at $388K in Q2 2021.
230 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2022.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2022, filed 25 Oct 2022.